We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.61B
AUM Growth
+$95.7M
Cap. Flow
-$7.31M
Cap. Flow %
-0.45%
Top 10 Hldgs %
28.48%
Holding
136
New
14
Increased
29
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$22.4M
2
AVXS
AveXis, Inc. Common Stock
AVXS
+$19.4M
3
HUBS icon
HubSpot
HUBS
+$14M
4
AIMT
Aimmune Therapeutics
AIMT
+$13.7M
5
APTV icon
Aptiv
APTV
+$13.2M

Top Sells

Rank Stock Value
1
ROL icon
Rollins
ROL
+$21.9M
2
AYI icon
Acuity Brands
AYI
+$17.5M
3
LRCX icon
Lam Research
LRCX
+$14.7M
4
OPLN
Openlane
OPLN
+$13.9M
5
XPO icon
XPO
XPO
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 35.06%
2 Technology 14.25%
3 Consumer Discretionary 14.02%
4 Industrials 8.96%
5 Utilities 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTD icon
26
Trade Desk
TTD
$8.59B
$24.6M 1.53%
+4,900,000
New +$22.4M
OPLN
27
Openlane
OPLN
$4.29B
$24.2M 1.51%
1,524,434
-853,366
-36% -$13.9M
CRUS icon
28
Cirrus Logic
CRUS
$6.65B
$23.2M 1.44%
370,000
– –
ARW icon
29
Arrow Electronics
ARW
$10.9B
$23.1M 1.44%
295,000
– –
PFPT
30
DELISTED
Proofpoint, Inc.
PFPT
$23M 1.43%
265,000
-55,000
-17% -$4.52M
CAFD
31
DELISTED
8point3 Energy Partners LP
CAFD
$22.3M 1.39%
1,471,100
-8,500
-0.6% -$112K
IDTI
32
DELISTED
Integrated Device Technology I
IDTI
$21.3M 1.33%
826,000
-220,700
-21% -$5.37M
AIMT
33
DELISTED
Aimmune Therapeutics
AIMT
$21.2M 1.32%
1,030,000
+720,000
+232% +$13.7M
PEGI
34
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$21.1M 1.32%
886,000
-4,000
-0.4% -$89.6K
AY
35
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$20.4M 1.27%
954,000
+31,000
+3% +$638K
XLRN
36
DELISTED
Acceleron Pharma
XLRN
$19.9M 1.24%
653,900
– –
INST
37
DELISTED
Instructure, Inc.
INST
$19.8M 1.23%
670,000
– –
TWLO icon
38
Twilio
TWLO
$29B
$19.4M 1.21%
665,000
– –
IPHI
39
DELISTED
INPHI CORPORATION
IPHI
$19M 1.19%
555,000
– –
FPRX
40
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$18.1M 1.13%
601,000
– –
VCYT icon
41
Veracyte
VCYT
$4.77B
$17.8M 1.11%
2,133,500
– –
ASND icon
42
Ascendis Pharma A/S
ASND
$16.5B
$17.8M 1.11%
640,000
+393,900
+160% +$10.4M
HASI icon
43
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$16M 1%
700,000
-4,000
-0.6% -$88.5K
AGIO icon
44
Agios Pharmaceuticals
AGIO
$1.95B
$15.5M 0.96%
300,800
– –
VMC icon
45
Vulcan Materials
VMC
$35.1B
$13.9M 0.87%
110,000
– –
APTV icon
46
Aptiv
APTV
$12.3B
$13.8M 0.86%
+158,000
New +$13.2M
HUBS icon
47
HubSpot
HUBS
$11.9B
$13.7M 0.85%
+208,000
New +$14M
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$13.4M 0.84%
265,000
– –
TSLA icon
49
Tesla
TSLA
$1.22T
$10.8M 0.68%
450,000
-150,000
-25% -$3.3M
STML
50
DELISTED
Stemline Therapeutics, Inc.
STML
$9.99M 0.62%
1,086,400
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Eventide Asset Management held 136 positions worth $1.61B, up 6.3% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management's Q2 2017 filing shows 14 new, 29 increased, 19 reduced and 10 closed positions. Its largest new stake was Trade Desk: 4,900,000 shares worth $24.6M. The largest sale was Rollins, an estimated $21.9M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q2 2017 buy was Trade Desk: 4,900,000 shares worth $24.6M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q2 2017, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q2 2017 reduction was Acuity Brands, cutting an estimated $17.5M.
  • Eventide Asset Management fully exited Rollins in Q2 2017, selling an estimated $21.9M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $1.61B portfolio in Q2 2017.
  • Eventide Asset Management opened 14 new positions and closed 10 in Q2 2017.
  • Eventide Asset Management's portfolio value rose 6.3% quarter-over-quarter to $1.61B.

Based on Eventide Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.